Skip to main content

Problems in the Treatment of Disseminated Cancer of the Breast: Selection of Patients for Hormone Treatment

  • Chapter
New Trends in the Treatment of Cancer

Abstract

The treatment of disseminated breast cancer consists first of modification of the hormonal environment of the patient. This can be done either by hormonal deprivation — oophorectomy, adrenalectomy, or hypophysectomy — or by the administration of hormones, usually steroids, androgens, estrogens, and corticosteroids. Only when these therapeutic measures have failed is it advisable to have recourse to non-hormonal cytotoxic agents, such as the alkylating drugs and 5-fluorouracil. One exception to this rule may be the group of patients less than one year postmenopausal. These are notoriously resistant to hormonal manipulation, whether surgical (hormonal deprivation) or medical (hormonal administration). This is why a clinical investigation is now being conducted with the aim of discovering whether the use of 5-fluorouracil or of some alkylating agent should precede hormone treatment in this particular group of patients, as the only exception to the general rule.

This work was supported by Grant Ca 4896-03 of the National Institutes of Health, Bethesda, Md., United States of America, for a co-operative study organized in Europe, and by Contract Euratom-ULB-Pise no. 026-63-4 BIAC. The European Breast Cancer Group is now part of the Groupe Européen de Chimiothérapie anti-cancéreuse.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bloom, H. J. G.: Natural history of untreated breast cancer. Ann. N. Y. Acad. Sci. 114, 747 (1964).

    Article  Google Scholar 

  • Bulbrook, R. D.: Hormone assays in human breast cancer. Vit. and Horm. 23, 329 (1965).

    Article  CAS  Google Scholar 

  • Dao, T. L., and E. Tan: A comparative evaluation of adrenalectomy and androgens in advanced mammary cancer. Cancer Chemother. Rep. 16, 309 (1962).

    PubMed  CAS  Google Scholar 

  • European Breast Cancer Group: Testosterone propionate therapy of breast cancer: a progress report. Cancer Chemother. Rep. 16, 273 (1962).

    Google Scholar 

  • European Breast Cancer Group: Study No. 3 (to be published).

    Google Scholar 

  • Groupe Européen du Cancer du Sein (Coordinateur: H. J. Tagnon): Le traitement hormonal du cancer du sein en phase avancée. Comparaison des résultats obtenus au moyen de la delta-1-testololactone et du propionate de testostérone. Rev. franç. Etud. clin. biol. 7, 1067 (1962).

    Google Scholar 

  • Groupe Européen du Cancer du Sein (Coordinateur: H. J. Tagnon): Le traitement hormonal du cancer du sein en phase avancée. Comparaison entre le propionate de testostérone et la combinaison propionate de testosterone — delta-1-testololactone. Rev. franç. Etud. clin. biol. 9, 88 (1964).

    Google Scholar 

  • Huggins, C. B.: Propositions in hormonal treatment of advanced cancers. J. Amer. med. Ass. 192, 1141 (1965).

    Article  CAS  Google Scholar 

  • Karhausen, L., Y. Kenis, J. Smulders, et R. Parmentier: Hypercalcémie et néphrocalcinose: étude de 4 cas de cancer du sein avec métastases osseuses. Acta clin. belg. 10, 296 (1955).

    PubMed  CAS  Google Scholar 

  • Kenis, Y., P. Dustin, J. A. Henry, et H. J. Tagnon: Action du Myleran dans 22 cas de leucémie myéloïde chronique. Rev. franç. Etud. clin. biol. 1, 435 (1956).

    PubMed  CAS  Google Scholar 

  • Kennedy, B. J.: Massive estrogen administration in premenopausal women with advanced breast cancer. Cancer Chemother. Rep. 16, 283 (1962).

    PubMed  CAS  Google Scholar 

  • MacDonald, I.: Endocrine ablation in disseminated mammary carcinoma. Surg. Gynec. Obstet. 115, 215 (1962).

    PubMed  CAS  Google Scholar 

  • Nissen Meyer, R., and J. H. Vogt: Cortisone treatment of metastatic breast cancer. Acta Un. int. Cancr. 15, 2240 (1959).

    Google Scholar 

  • Pearson, O. H.: Observations on the role of androgens and estrogens in body balance. Arch. intern. Med. 100, 724 (1957).

    Article  CAS  Google Scholar 

  • Segaloff, A.: Testosterone propionate therapy of breast cancer. A report for the cooperative breast cancer group. In Pincus, G., and E. P. Vollmer (ed.): Biological activities of steroids in relation to cancer. New York and London: Academic Press 1960.

    Google Scholar 

  • Segaloff, A. et al.: Study No. 2 of the Cooperative Breast Cancer Group. Cancer Chemother. Rep. 11, 109 (1961).

    Google Scholar 

  • Segaloff, A. et al.: Breast cancer. St. Louis: C.V. Mosby: 1958, pages 193–195.

    Google Scholar 

  • Tagnon, H. J., P. Shulman, W. F. Whitmore, and L. A. Leone: Prostatic fibrinolysin. Role in hemorrhagic diathesis of cancer of the prostate. Amer. J. Med. 15, 875–884 (1953).

    Article  PubMed  CAS  Google Scholar 

  • Tagnon, H. J., P. Shulman, W. F. Whitmore, and L. A. Leone: Traitement hormonal du cancer du sein en phase avancée. Brux. méd. 41, 817 (1961).

    PubMed  CAS  Google Scholar 

  • Tagnon, H. J., and A. Steens-Lievens: Studies of fibrinolysis and acid phosphatase in cancer of the prostate. Biology of the prostate and related tissues. Washington: National Cancer Institute 1963 (Monograph No. 12).

    Google Scholar 

  • Tagnon, H. J., and A. Steens-Lievens: La dépendance hormonale dans les cancers mammaires. Méd. et Hyg. (Genève) 22, 1001 (1964 a).

    Google Scholar 

  • Tagnon, H. J., and A. Steens-Lievens: Clinical results with hormones in disseminated mammary cancer. In Plattner, P. A. (ed.): Chemotherapy of cancer. Amsterdam and New York: Elsevier 1964 b.

    Google Scholar 

  • Van Gilse, H. A.: Long term treatment with corticosteroids of patients with metastatic breast cancer. Cancer Chemother. Rep. 16, 293 (1962).

    PubMed  Google Scholar 

  • Van Rymenant, M., A. Coune, H. J. Tagnon, et S. Simon: Le traitement hormonal du cancer du sein en phase avancée. Méthodes d’étude: comparaison de la delta-1-testololactone avec le propionate de testostérone. Acta clin. belg. 18, 469 (1963).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1967 Springer-Verlag Berlin · Heidelberg

About this chapter

Cite this chapter

Tagnon, H.J., Coune, A., Heuson, J.C., van Rymenant, M. (1967). Problems in the Treatment of Disseminated Cancer of the Breast: Selection of Patients for Hormone Treatment. In: Manuila, L., Moles, S., Rentchnick, P. (eds) New Trends in the Treatment of Cancer. Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, vol 8. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-87620-2_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-87620-2_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-87622-6

  • Online ISBN: 978-3-642-87620-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics